Sunoco CFO Joins Fox Chase Cancer Center Board
PHILADELPHIA (June 19, 2000) -- Thomas W. Hofmann of Malvern, Pa., vice president and chief financial officer of Sunoco, Inc., in Philadelphia, has been elected to the board of directors of Fox Chase Cancer Center. Hoffman will serve on the board's finance committee and investment subcommittee.
"I am proud to serve on the board of directors of such a high-quality, dynamic and progressive research center and hospital," said Hofmann. "Fox Chase scientists and physicians rank among the best in the nation. With the opening of its new Research Institute for Cancer Prevention, Fox Chase has extended its mission not only to improve cancer treatment but to prevent cancer wherever possible."
Hofmann became Sunoco's chief financial officer in July 1998. He has overall responsibility for the corporation's financial functions and strategic planning. The Radnor Corporation, a Sunoco real estate subsidiary, is also a part of his responsibilities.
After working for the accounting firm of Coopers & Lybrand, Hofmann joined Sunoco in 1977 as manager of consolidation accounting in the comptroller's office. He held other management assignments in that office and in 1987 became vice president of finance for Helios Capital Organization, then a Sunoco subsidiary involved in equipment leasing.
He next served as Sunoco's comptroller from 1990 to 1991, as director of tax administration from 1991 to 1994 and as director of performance analysis until 1995, when he returned to the position of comptroller for three years before becoming CFO of Sunoco.
Hofmann received his bachelor of science degree in accounting from the University of Delaware in 1973 and his master's in taxation from Villanova University in 1994. He is a member of the American Institute of Certified Public Accountants and the Pennsylvania Institute of Certified Public Accountants.
In addition to the Fox Chase board, Hofmann serves as a board member and treasurer of the Boys & Girls Club of Greater Philadelphia. He is also on the boards of Bryn Mawr Rehab and the Devon Preparatory School. He and his wife, Katherine, have two children.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at: www.fccc.edu
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.